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Test Statistics Null Distributions in Multiple
Testing: Simulation Studies and Applications
to Genomics
Katherine S. Pollard, Merrill D. Birkner, Mark J. van der Laan, and Sandrine
Dudoit

Abstract

Multiple hypothesis testing problems arise frequently in biomedical and genomic
research, for instance, when identifying differentially expressed or co-expressed
genes in microarray experiments. We have developed generally applicable resamplingbased single-step and stepwise multiple testing procedures (MTP) for control of a
broad class of Type I error rates, defined as tail probabilities and expected values
for arbitrary functions of the numbers of false positives and rejected hypotheses (Dudoit and van der Laan, 2005; Dudoit et al., 2004a,b; Pollard and van der
Laan, 2004; van der Laan et al., 2005, 2004a,b). As argued in the early article
of Pollard and van der Laan (2004), a key feature of the methodology is the general characterization and explicit construction of a test statistics null distribution
(rather than data generating null distribution), which provides Type I error control
in testing problems involving general data generating distributions (with arbitrary
dependence structures among variables), null hypotheses, and test statistics. In
particular, the proposed null distribution provides Type I error control without requirements such as subset pivotality (Westfall and Young, 1993) and, therefore,
allows one to test hypotheses about a much broader class of parameters than are
covered by currently available methods (e.g., correlation coefficients, regression
parameters in linear and non-linear models with dependent covariates and error
terms).
This paper presents simulation studies comparing test statistics null distributions
in two testing scenarios of great relevance to biomedical and genomic data analysis: tests for regression parameters in linear models where covariates and error

terms are allowed to be dependent and tests for correlation coefficients. The simulation studies demonstrate that the choice of null distribution can have a substantial impact on the Type I error and power properties of a given multiple testing
procedure. Procedures based on a general non-parametric bootstrap estimator of
the proposed test statistics null distribution typically control the Type I error rate
“on target” at the nominal level. In contrast, comparable procedures, based on
parameter-specific bootstrap null distributions, can be severely anti-conservative
(bootstrapping residuals for the test of regression parameters) or conservative (independent bootstrap for the test of correlation coefficients). Applications to a
novel genomic dataset, from a study of microRNA expression in cancer, illustrate
the flexibility and power of our proposed methodology (Lu et al., 2005).

1
1.1

Introduction
Motivation

The genomic age has brought growing interest in multiple testing. As new
technologies, such as microarrays, mass spectrometry, and high-throughput
sequencing, facilitate the collection of high-dimensional biological datasets,
researchers are becoming increasingly reliant on statistical methods for assessing the signiﬁcance of biological ﬁndings over families of thousands or
even millions of hypothesis tests. Identifying diﬀerentially expressed or coexpressed genes from genome-wide mRNA abundance data are classic examples. Other applications include: tests of association between gene expression
measures and Gene Ontology (GO) annotation (Dudoit and van der Laan
(2005); www.geneontology.org); the identiﬁcation of transcription factor
binding sites in ChIP-Chip experiments, where chromatin immunoprecipitation (ChIP) of transcription factor-bound DNA is followed by microarray hybridization (Chip) of the IP-enriched DNA (Keleş et al., 2004); tests of association between phenotypes and amino acid mutations, e.g., viral replication
capacity and HIV-1 sequence variation (Birkner et al., 2005b,c; van der Laan
et al., 2005); the genetic mapping of complex traits using single nucleotide
polymorphisms (SNP) (Birkner et al., 2005a). These testing problems are
particularly challenging, as they involve inference for large multivariate distributions, with complex and unknown dependence structures among variables.
Therefore, existing methods, based solely on the marginal distributions of the
test statistics and/or simplifying assumptions about their joint distribution,
are generally not appropriate.
Motivated by the aforementioned biomedical and genomic applications
and the limitations of existing multiple testing methods, we have developed
and implemented (in R and SAS) resampling-based single-step and stepwise
multiple testing procedures (MTP) for controlling a broad class of Type I error rates, in testing problems involving general data generating distributions
(with arbitrary dependence structures among variables), null hypotheses (deﬁned in terms of submodels for the data generating distribution), and test
statistics (e.g., t-statistics, F -statistics) (Dudoit and van der Laan, 2005; Dudoit et al., 2004a,b; Pollard and van der Laan, 2004; van der Laan et al., 2005,
2004a,b). In particular, procedures that take into account the joint distribution of the test statistics are provided to control Type I error rates deﬁned
as tail probabilities and expected values for arbitrary functions g(Vn , Rn ) of
1
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the numbers of false positives Vn and rejected hypotheses Rn . The following
quantities are derived to summarize the results of a MTP: rejection regions
(i.e., cut-oﬀs) for the test statistics, conﬁdence regions for the parameters of
interest, and adjusted p-values.
As demonstrated in the early article of Pollard and van der Laan (2004),
a key feature of our proposed MTPs is the test statistics null distribution
(rather than data generating null distribution) used to obtain rejection regions, conﬁdence regions, and adjusted p-values. Whether testing single or
multiple hypotheses, one needs the (joint) distribution of the test statistics
in order to derive a procedure that probabilistically controls Type I errors.
In practice, however, the true distribution of the test statistics is unknown
and replaced by a null distribution. The choice of a suitable null distribution
is crucial, in order to ensure that (ﬁnite sample or asymptotic) control of the
Type I error rate under the assumed null distribution does indeed provide
the required control under the true distribution. This issue is particularly
relevant for large-scale testing problems such as those described above in
biomedical and genomic research.
Common approaches use a data generating distribution, such as a permutation distribution, that satisﬁes the complete null hypothesis that all null
hypotheses are true. Procedures based on such a data generating null distribution typically rely on the subset pivotality condition stated in Westfall and
Young (1993), p. 42–43, to ensure that control under the data generating
null distribution does indeed give the desired control under the true data
generating distribution. However, the subset pivotality condition is violated
in many important testing problems, since a data generating null distribution
may result in a joint distribution for the test statistics that has a diﬀerent
dependence structure than their true distribution. In fact, in most problems,
there does not even exist a data generating null distribution that correctly
speciﬁes the joint distribution of the test statistics corresponding to the true
null hypotheses.
Indeed, subset pivotality fails for two types of testing problems that are
highly relevant in biomedical and genomic data analysis: tests concerning
correlation coeﬃcients and tests concerning regression parameters. Tests of
correlation arise, for example, when seeking to discover sets of co-expressed
genes based on microarray expression measures. Tests concerning regression parameters in linear, logistic, survival, and other non-linear models, are
commonly used, particularly in medical applications, to identify genes or genomic regions associated with a possibly censored outcome (e.g., survival,
2
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tumor class, response to treatment). While subset pivotality holds for some
regression models, such as the simple linear model with independent covariates and error terms, it fails for many models used in practice (e.g., linear
regression model of Section 3.1 and logistic regression model of Section 4).

1.2

Outline

The present article, inspired by the early work of Pollard and van der Laan
(2004), concerns the choice of a test statistics null distribution in multiple
testing. Speciﬁcally, it investigates the Type I error and power properties
of multiple testing procedures based on our general bootstrap null distribution (Dudoit and van der Laan, 2005; Dudoit et al., 2004b; Pollard and
van der Laan, 2004) and various parameter-speciﬁc bootstrap null distributions (Westfall and Young, 1993). For the purpose of comparing null distributions, we focus on control of the family-wise error rate (FWER), using
the single-step maxT procedure, a common cut-oﬀ procedure exploiting the
joint distribution of the test statistics. Note, however, that each null distribution could be employed with any other MTP, including our stepwise
joint augmentation and empirical Bayes procedures, for controlling generalized tail probability (gTP) error rates, gT P (q, g) = P r(g(Vn , Rn ) > q), for
an arbitrary function g(Vn , Rn ) of the numbers of false positives Vn and rejected hypotheses Rn (Dudoit and van der Laan, 2005; Dudoit et al., 2004a,b;
Pollard and van der Laan, 2004; van der Laan et al., 2005, 2004a,b).
Section 2 provides an overview of our general framework for multiple hypothesis testing and our approach to Type I error control and the choice
of a test statistics null distribution. Section 3 describes simulation studies
comparing test statistics null distributions in two testing scenarios. The ﬁrst
simulation study considers tests for regression parameters in linear models with dependent covariates and error terms and compares our general
non-parametric bootstrap test statistics null distribution (Procedure 2) to
a bootstrap null distribution which involves resampling residuals (Westfall
and Young (1993), Section 3.4.1, p. 106–109). The second simulation study
considers tests for correlation coeﬃcients and compares our general nonparametric bootstrap test statistics null distribution (Procedure 2) to a bootstrap null distribution which involves resampling individual variables independently (Westfall and Young (1993), Section 6.3, p. 194). The simulation
studies demonstrate that the choice of null distribution can have a substantial impact on the Type I error and power properties of a given multiple
3
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testing procedure, such as the single-step maxT MTP. Section 4 applies the
single-step maxT procedure, based on the general non-parametric bootstrap
test statistics null distribution of Procedure 2, to a dataset of microRNA
(miRNA) expression measures from cancerous and healthy tissues (Lu et al.,
2005). The ﬁrst testing problem concerns parameters in a (non-linear) logistic regression model relating miRNA expression measures to cancer status,
while the second concerns pairwise correlations for miRNA expression measures. We identify 102 (66% of the 155 studied) single miRNAs signiﬁcantly
associated with cancer status, as well as hundreds of pairs of miRNAs with
signiﬁcantly correlated proﬁles across samples. Finally, Section 5 closes with
conclusions and a discussion of ongoing eﬀorts.

2
2.1

Methods
Multiple hypothesis testing framework

The present section introduces a general statistical framework for multiple
hypothesis testing and discusses in turn the main ingredients of a multiple
testing problem. The reader is referred to Dudoit and van der Laan (2005)
and Dudoit et al. (2004b) for details.
2.1.1

Data generating distribution and parameters

Consider a random sample, Xn ≡ {X1 , . . . , Xn }, of n independent and identically distributed (i.i.d.) random variables from a data generating distribution
i.i.d.
P : Xi ∼ P , i = 1, . . . , n. Suppose that the data generating distribution P
is an element of a particular statistical model M, i.e., a set of possibly nonparametric distributions, P ∈ M. Let Pn denote the corresponding empirical
distribution, which places probability 1/n on each realization of X.
Deﬁne parameters as arbitrary functions of the data generating distribution P : Ψ(P ) = ψ = (ψ(m) : m = 1, . . . , M ), where ψ(m) = Ψ(P )(m) ∈ IR.
2.1.2

Null and alternative hypotheses

General submodel hypotheses. In order to cover a broad class of testing
problems, deﬁne M pairs of null and alternative hypotheses in terms of a
collection of submodels, M(m) ⊆ M, m = 1, . . . , M , for the data generating
distribution P . The M null hypotheses are deﬁned as H0 (m) ≡ I(P ∈ M(m))
4
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and the corresponding alternative hypotheses as H1 (m) ≡ I(P ∈
/ M(m)).
Here, I(·) is the indicator function, equaling 1 if the condition in parentheses is true and 0 otherwise. Thus, H0 (m) is true, i.e., H0 (m) = 1, if the
data generating distribution P belongs to submodel M(m); H0 (m) is false
otherwise, i.e., H0 (m) = 0.
This general submodel representation covers tests of means, quantiles,
correlation coeﬃcients, and regression coeﬃcients in linear and non-linear
models (e.g., logistic, survival, time-series, and dose-response models).
Parametric hypotheses. In many testing problems, the submodels concern
parameters, i.e., each null hypothesis may refer to a single parameter, ψ(m) =
Ψ(P )(m) ∈ IR. One distinguishes between two types of testing problems for
parametric hypotheses, one-sided and two-sided tests.


One-sided tests
H0 (m) = I ψ(m) ≤ ψ0 (m)


vs.
H1 (m) = I ψ(m) > ψ0 (m) , m = 1, . . . , M.
Two-sided tests
vs.



H0 (m) = I ψ(m) = ψ0 (m)


H1 (m) = I ψ(m) = ψ0 (m) ,

m = 1, . . . , M.

The hypothesized null values, ψ0 (m), are frequently zero. For instance, in
microarray data analysis, one may be interested in testing the null hypotheses H0 (m) of no diﬀerences in mean gene expression measures between two
populations of patients or of no correlation between pairs of gene expression
proﬁles.
Sets of true and false null hypotheses. Let H0 = H0 (P ) ≡ {m :
H0 (m) = 1} = {m : P ∈ M(m)} be the set of h0 ≡ |H0 | true null hypotheses, where we note that H0 depends on the data generating distribution P .
/ M(m)} be the
Let H1 = H1 (P ) ≡ H0c (P ) = {m : H1 (m) = 1} = {m : P ∈
set of h1 ≡ |H1 | = M − h0 false null hypotheses, i.e., true positives. The goal
of a multiple testing procedure is to accurately estimate the set H0 , and thus
its complement H1 , while probabilistically controlling false positives.

Complete null hypothesis. The complete null hypothesis, H0C ≡ M
m=1 H0 (m) =
M
M
m=1 I(P ∈ M(m)) = I(P ∈ ∩m=1 M(m)), is true if and only if all M individual null hypotheses H0 (m) are true, i.e., if and only if the data generating
distribution P belongs to the intersection ∩M
m=1 M(m) of the M submodels.
5
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2.1.3

Multiple testing procedure

Test statistics. A testing procedure is a data-driven rule for deciding which
null hypotheses should be rejected, i.e., which H0 (m) should be declared false
(zero), so that P ∈
/ M(m). The decisions to reject or not the null hypotheses
are based on an M –vector of test statistics, Tn = (Tn (m) : m = 1, . . . , M ),
that are functions Tn (m) = T (m; X1 , . . . , Xn ) of the data, X1 , . . . , Xn . Denote the typically unknown (ﬁnite sample) joint distribution of the test statistics Tn by Qn = Qn (P ).
For the test of single-parameter null hypotheses, H0 (m) = I(ψ(m) ≤
ψ0 (m)) or H0 (m) = I(ψ(m) = ψ0 (m)), m = 1, . . . , M , consider two main
types of test statistics, diﬀerence statistics,
√
(1)
Tn (m) ≡ Estimator − Null value = n(ψn (m) − ψ0 (m)),
and t-statistics (i.e., standardized diﬀerences),
Tn (m) ≡

Estimator − Null value √ ψn (m) − ψ0 (m)
= n
.
Standard error
σn (m)

(2)

Here, Ψ̂(Pn ) = ψn = (ψn (m) : m = 1, . . . , M ) denotes an estimator
√ for the
parameter Ψ(P ) = ψ = (ψ(m) : m = 1, . . . , M ) and (σn (m)/ n : m =
1, . . . , M ) denote the estimated standard errors for components ψn (m) of
ψn . Test statistics for other types of null hypotheses include χ2 -statistics,
F -statistics, and likelihood ratio statistics.
Multiple testing procedure. A multiple testing procedure (MTP) provides rejection regions, Cn (m), i.e., sets of values for each test statistic Tn (m)
that lead to the decision to reject the corresponding null hypothesis H0 (m)
and declare that P ∈
/ M(m), m = 1, . . . , M . In other words, a MTP produces a random (i.e., data-dependent) subset Rn of rejected hypotheses that
estimates H1 , the set of true positives,
Rn = R(Tn , Q0n , α) ≡ {m : H0 (m) is rejected} = {m : Tn (m) ∈ Cn (m)},
(3)
where Cn (m) = C(m; Tn , Q0n , α), m = 1, . . . , M , denote possibly random
rejection regions. The long notation R(Tn , Q0n , α) and C(m; Tn , Q0n , α) emphasizes that the MTP depends on:
1. the data, Xn = {Xi : i = 1, . . . , n}, through the M –vector of test
statistics, Tn = (Tn (m) : m = 1, . . . , M );
6
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2. an M –variate (estimated) test statistics null distribution, Q0n , for deriving rejection regions, conﬁdence regions, and adjusted p-values;
3. the nominal level α of the MTP, i.e., the desired upper bound for a
suitably deﬁned Type I error rate.
Rejection regions. Rejection regions are typically deﬁned in terms of intervals, such as, Cn (m) = (un (m), +∞), Cn (m) = (−∞, ln (m)), and Cn (m) =
(−∞, ln (m)) ∪ (un (m), +∞), where ln (m) = l(m; Tn , Q0n , α) and un (m) =
u(m; Tn , Q0n , α) are to-be-determined lower and upper critical values, or cutoﬀs, computed under the null distribution Q0n for the test statistics Tn .
Rejection regions of the form Cn (m) = (−∞, ln (m)) ∪ (un (m), +∞) allow the
use of asymmetric cut-oﬀs for two-sided tests. Unless speciﬁed otherwise, assume that large values of the test statistic Tn (m) provide evidence against the
corresponding null hypothesis H0 (m), that is, consider rejection regions of
the form Cn (m) = (cn (m), +∞), based on cut-oﬀs cn (m) = c(m; Tn , Q0n , α).
For two-sided tests of single-parameter null hypotheses using diﬀerence or
t-statistics (Equations (1) and (2)), one could take absolute values of the
test statistics.
2.1.4

Type I error rate and power

Type I and Type II errors. In any testing situation, two types of errors
can be committed: a false positive, or Type I error, is committed by rejecting
a true null hypothesis, and a false negative, or Type II error, is committed
when the test procedure fails to reject a false null hypothesis. The situation
can be summarized by
1, below, where the number of rejected hypotheTable
M
ses is Rn ≡ |Rn | = m=1 I(Tn (m) ∈ Cn (m)), the number of Type I errors
I(Tn (m) ∈ Cn (m)), and the number of Type II
is Vn ≡ |Rn ∩ H0 | = m∈H0 
/ Cn (m)). Note that both Un
errors is Un ≡ |Rcn ∩ H1 | = m∈H1 I(Tn (m) ∈
and Vn depend on the unknown data generating distribution P through the
unknown set of true null hypotheses H0 = H0 (P ). Therefore, the numbers
h0 = |H0 | and h1 = |H1 | = M − h0 of true and false null hypotheses are
unknown parameters, the number of rejected hypotheses Rn is an observable
random variable, and the entries in the body of the table, Un , h1 − Un , Vn ,
and h0 − Vn , are unobservable random variables.
Ideally, one would like to simultaneously minimize both the number of
Type I errors and the number of Type II errors. Unfortunately, this is not

7
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feasible and one seeks a trade-oﬀ between the two types of errors. A standard approach is to specify an acceptable level α for a suitably deﬁned Type
I error rate and derive testing procedures that aim to minimize a Type II
error rate, i.e., maximize power, within the class of tests with Type I error
rate at most α.
Type I error rate. When testing multiple hypotheses, there are many
possible deﬁnitions for the Type I error rate of a test procedure. Accordingly,
we adopt a general deﬁnition for Type I error rates, as parameters, θn =
θ(FVn ,Rn ), of the joint distribution FVn ,Rn of the numbers of Type I errors
Vn = |Rn ∩ H0 | and rejected hypotheses Rn .
This article focuses on the family-wise error rate (FWER), that is, the
probability of at least one Type I error,
F W ER ≡ P r(Vn > 0) = 1 − FVn (0).

(4)

The FWER is controlled, in particular, by the classical Bonferroni procedure
(Section 2.3).
Power. As with Type I error rates, power can be deﬁned generally as a
parameter, ϑn = ϑ(FUn ,Rn ), of the joint distribution FUn ,Rn of the numbers
of Type II errors Un = |Rcn ∩ H1 | and rejected hypotheses Rn .
The present article assesses multiple testing procedures in terms of their
average power, or expected proportion of rejected false null hypotheses,

1
1
udFUn (u).
(5)
AvgP wr ≡ E[h1 − Un ] = 1 −
h1
h1
A variety of other Type I and II error rates are discussed in Dudoit and
van der Laan (2005).
2.1.5

Adjusted p-values

The notion of p-value extends directly to multiple testing problems as follows.
Consider any multiple testing procedure Rn (α) = R(Tn , Q0n , α), with rejection regions Cn (m; α) = C(m; Tn , Q0n , α). Then, one can deﬁne an M –vector
of adjusted p-values, P0n = (P0n (m) : m = 1, . . . , M ), as
P0n (m) ≡ inf {α ∈ [0, 1] : Reject H0 (m) at nominal MTP level α} (6)
= inf {α ∈ [0, 1] : m ∈ Rn (α)}
m = 1, . . . , M.
= inf {α ∈ [0, 1] : Tn (m) ∈ Cn (m; α)} ,
8
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That is, the adjusted p-value P0n (m), for null hypothesis H0 (m), is the smallest nominal Type I error level of the multiple hypothesis testing procedure
(e.g., FWER or any other Type I error rate) at which one would reject H0 (m),
given Tn . Note that the unadjusted p-value P0n (m), for the individual test of
null hypothesis H0 (m), corresponds to the special case M = 1.
As in single hypothesis tests, the smaller the adjusted p-value, the stronger
the evidence against the corresponding null hypothesis. Thus, one rejects
H0 (m) for small adjusted p-values P0n (m). This leads to two equivalent representations for a MTP, in terms of rejection regions for the test statistics
and in terms of adjusted p-values,
Rn (α) = {m : Tn (m) ∈ Cn (m; α)} = {m : P0n (m) ≤ α}.

2.2
2.2.1

(7)

Type I error rate control and choice of a null distribution
General test statistics null distribution

One of the main tasks in specifying a multiple testing procedure is to derive
rejection regions for the test statistics such that the Type I error rate is
controlled at a desired level α, i.e., such that
θ(FVn ,Rn ) ≤ α
lim sup θ(FVn ,Rn ) ≤ α

[ﬁnite sample control]
[asymptotic control].

(8)

n→∞

Note that the Type I error parameter θ(FVn ,Rn ) is deﬁned under the true
distribution Qn = Qn (P ) of the test statistics Tn , which is a function of
the true underlying data generating distribution P . In practice, however,
the distribution Qn (P ) is unknown and replaced by a null distribution Q0
(or estimate thereof, Q0n ). The choice of a suitable null distribution Q0 is
crucial, in order to ensure that (ﬁnite sample or asymptotic) control of the
Type I error rate under this assumed null distribution does indeed provide
the required control under the true distribution Qn (P ). For proper control,
the null distribution Q0 must be such that the Type I error rate under this
null distribution dominates the Type I error rate under the true distribution
Qn (P ). That is, the following null domination condition must be satisﬁed,
θ(FVn ,Rn ) ≤ θ(FV0 ,R0 )
lim sup θ(FVn ,Rn ) ≤ θ(FV0 ,R0 )

[ﬁnite sample control]
[asymptotic control],

(9)

n→∞

9
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where V0 and R0 denote, respectively, the numbers of Type I errors and
rejected hypotheses under Q0 , i.e., for Tn ∼ Q0 .
For error rates θ(FVn ), deﬁned as arbitrary parameters of the distribution
of the number of Type I errors Vn , we propose as null distribution Q0 =
Q0 (P ), the asymptotic distribution of the M –vector Zn of null value shifted
and scaled test statistics (Dudoit and van der Laan, 2005; Dudoit et al.,
2004b; Pollard and van der Laan, 2004; van der Laan et al., 2004b),


τ0 (m)
Zn (m) ≡ min 1,
Tn (m)+λ0 (m)−E[Tn (m)] , m = 1, . . . , M.
V ar[Tn (m)]
(10)
For the test of single-parameter null hypotheses using t-statistics, the null
values are λ0 (m) = 0 and τ0 (m) = 1. For testing the equality of K population means using F -statistics, the null values are λ0 (m) = 1 and τ0 (m) =
2/(K − 1), under the assumption of equal variances in the diﬀerent populations. Single-step and stepwise procedures based on such a null distribution
do indeed provide the desired asymptotic control of the Type I error rate
θ(FVn ), for general data generating distributions (with arbitrary dependence
structures among variables), null hypotheses (deﬁned in terms of submodels for the data generating distribution), and test statistics (e.g., t-statistics,
F -statistics).
For a broad class of testing problems, such as the test of single-parameter
null hypotheses using t-statistics (Equation (2)), the null distribution Q0 is
an M –variate Gaussian distribution with mean vector zero and covariance
matrix Σ (P ): Q0 = Q0 (P ) ≡ N (0, Σ (P )). For tests of means, where the
parameter of interest is the M –dimensional mean vector Ψ(P ) = ψ = E[X],
the estimator ψn is simply the M –vector of empirical means and Σ (P ) is the
correlation matrix Cor[X] of X ∼ P . More generally, for an asymptotically
linear estimator ψn , Σ (P ) is the correlation matrix of the vector inﬂuence
curve (IC). This situation covers standard one-sample and two-sample tstatistics for tests of means, but also test statistics for correlation coeﬃcients
(Equation (24)) and regression parameters in linear and non-linear models
(Equations (18) and (29)).
In practice, however, since the data generating distribution P is unknown,
then so is the proposed null distribution Q0 = Q0 (P ). Resampling procedures, such as the bootstrap procedures of Section 2.4, may be used to conveniently obtain consistent estimators Q0n of the null distribution Q0 and of
the resulting test statistic cut-oﬀs and adjusted p-values (Dudoit and van der
10
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Laan, 2005; Dudoit et al., 2004b; Pollard and van der Laan, 2004; van der
Laan et al., 2004b).
2.2.2

Contrast with other approaches

As detailed in Dudoit and van der Laan (2005), Dudoit et al. (2004b), and
Pollard and van der Laan (2004), the following two main points distinguish
our approach from existing approaches to Type I error rate control and the
choice of a null distribution (e.g., in Hochberg and Tamhane (1987) and
Westfall and Young (1993)).
Type I error control under the true data generating distribution.
Firstly, we are only concerned with control of the Type I error rate under
the true data generating distribution P , i.e., under the joint distribution
Qn = Qn (P ) for the test statistics Tn implied by P . The concepts of weak
control and strong control are therefore irrelevant in our context.
In particular, the notion of null domination (Dudoit and van der Laan,
2005; Dudoit et al., 2004b) diﬀers from that of subset pivotality (Westfall
and Young (1993), p. 42–43) in the following senses: (i) null domination
is only concerned with the true data generating distribution P , i.e., it only
considers the subset H0 (P ) of true null hypotheses and not all possible 2M
subsets J0 ⊆ {1, . . . , M } of null hypotheses, and (ii) null domination does
not require equality of the joint distributions Q0,H0 and Qn,H0 (P ) for the
H0 –speciﬁc test statistics, but the weaker domination of Qn,H0 (P ) by Q0,H0 .
Null distribution for the test statistics. Secondly, we propose a null
distribution for the test statistics (Tn ∼ Q0 ) rather than a data generating
null distribution (X ∼ P0 ). A common choice of data generating null distribution P0 is one that satisﬁes the complete null hypothesis, H0C = I(P ∈
M
∩M
m=1 M(m)), that all M null hypotheses are true, i.e., P0 ∈ ∩m=1 M(m). The
data generating null distribution P0 then implies a null distribution Qn (P0 )
for the test statistics.
As discussed in Pollard and van der Laan (2004), procedures based on
Qn (P0 ) do not necessarily provide proper (asymptotic) Type I error control
under the true distribution P . Indeed, the assumed null distribution Qn (P0 )
and the true distribution Qn (P ) for the test statistics Tn may converge to distributions with diﬀerent dependence structures and, as a result, may violate
the required null domination condition for the Type I error rate (Equation
11
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(9)). For instance, for test statistics with Gaussian asymptotic distributions,
the H0 –speciﬁc correlation matrix under the true distribution P may be
diﬀerent from the corresponding correlation matrix under the assumed complete null distribution P0 , that is, one may have ΣH0 (P ) = ΣH0 (P0 ). In the
two-sample testing problem, for the commonly-used permutation null distribution P0 , Pollard and van der Laan (2004) show that ΣH0 (P ) = ΣH0 (P0 )
only if (i) the two populations have the same covariance matrices or (ii) the
two sample sizes are equal.
Consequently, approaches based on permutation or other data generating
null distributions P0 (e.g., Korn et al. (2004), Troendle (1995, 1996), and
Westfall and Young (1993)) are only valid under certain assumptions for the
true data generating distribution P . In fact, in most testing problems, there
does not exist a data generating null distribution P0 ∈ ∩M
m=1 M(m) that
correctly speciﬁes a joint distribution for the test statistics, i.e., such that
the required null domination condition for the Type I error rate is satisﬁed.
Thus, unlike current procedures which can only be applied to a limited
set of multiple testing problems, the test statistics null distribution Q0 of
Equation (10) leads to single-step and stepwise procedures that provide the
desired (asymptotic) Type I error rate control for general data generating
distributions, null hypotheses, and test statistics. The null distribution Q0
can be used in testing problems which cannot be handled by traditional
approaches based on a data generating null distribution P0 and the associated
assumption of subset pivotality. Such problems include tests for correlation
coeﬃcients and regression parameters in models where covariates and error
terms are allowed to be dependent (Sections 3 and 4).

2.3

Multiple testing procedures

The classical single-step Bonferroni procedure is perhaps the most widelyused procedure for controlling the family-wise error rate. For a test at nominal FWER level α ∈ [0, 1], the procedure rejects any hypothesis H0 (m) with
unadjusted p-value P0n (m) less than or equal to the common single-step cutoﬀ α/M . The corresponding adjusted p-values are given by,


m = 1, . . . , M.
(11)
P0n (m) = min M P0n (m), 1 ,
While simple, this marginal procedure can be very conservative for even
moderate numbers M of hypotheses. As illustrated in Dudoit et al. (2004a,
12
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2003) and van der Laan et al. (2005), substantial gains in power can be
achieved by taking into account the joint distribution of the test statistics,
as in the following procedure.
Procedure 1 [FWER-controlling single-step maxT procedure] The
single-step maxT procedure is a joint common-cut-oﬀ procedure based on the
distribution of the maximum test statistic, maxm∈{1,...,M } Z(m), for an M –
vector Z = (Z(m) : m = 1, . . . , M ) ∼ Q0 with test statistics null distribution
Q0 . For controlling the FWER at nominal level α ∈ [0, 1], the common cutoﬀ c(Q0 , α), for the test statistics Tn = (Tn (m) : m = 1, . . . , M ), is the
(1 − α)–quantile of the distribution of maxm∈{1,...,M } Z(m) under Q0 ,

c(Q0 , α) ≡ inf c ∈ IR : P rQ0
max Z(m) ≤ c ≥ (1 − α) . (12)
m∈{1,...,M }

The corresponding adjusted p-values are given by


P0n (m) = P rQ0
max Z(m) ≥ Tn (m) ,
m∈{1,...,M }

m = 1, . . . , M.

(13)

For a test at nominal FWER level α, one has two equivalent representations of the set Rn (α) of rejected hypotheses, in terms of cut-oﬀs for the test
statistics and in terms of adjusted p-values,
Rn (α) = {m : Tn (m) > c(Q0 , α)} = {m : P0n (m) ≤ α}.
The reader is referred to our earlier articles and book in preparation,
for a variety of other joint multiple testing procedures, controlling a broad
class of Type I error rates deﬁned as tail probabilities and expected values
for arbitrary functions g(Vn , Rn ) of the numbers of false positives Vn and rejected hypotheses Rn (Dudoit and van der Laan, 2005; Dudoit et al., 2004a,b;
Pollard and van der Laan, 2004; van der Laan et al., 2005, 2004a,b).

2.4

Bootstrap-based multiple testing procedures

The test statistics null distribution Q0 = Q0 (P ) deﬁned in Equation (10)
depends on the true data generating distribution P and is therefore typically
unknown. It can be estimated with the (non-parametric or model-based)
bootstrap as detailed in Procedure 2, below. Bootstrap-based test statistic cut-oﬀs and adjusted p-values for FWER-controlling single-step maxT
Procedure 1 may then be obtained as in Procedure 3.
13
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Procedure 2 [Bootstrap estimation of the test statistics null distribution Q0 ] Let Pn denote an estimator of the true data generating distribution P . For the non-parametric bootstrap, Pn is simply the empirical
distribution Pn , that is, samples of size n are drawn at random, with replacement from the observed data, Xn = {Xi : i = 1, . . . , n}. For the model-based
bootstrap, Pn belongs to a model M for the data generating distribution P ,
such as a family of multivariate Gaussian distributions. One then proceeds
as follows to generate the bootstrap test statistics null distribution.
1. Obtain the bth bootstrap dataset, Xnb ≡ {Xib : i = 1, . . . , n}, b =
1, . . . , B, by generating n i.i.d. random variables Xib with distribution
Pn .
2. For each bootstrap dataset Xnb , compute an M –vector of test statistics,
Tn (·, b) = (Tn (m, b) : m
 = 1, . .. , M ), which can be arranged in an
M × B matrix, Tn ≡ Tn (m, b) , with rows corresponding to the M
null hypotheses and columns to the B bootstrap samples.
3. 
For each null hypothesis H0 (m), compute empirical
 means E[Tn (m, ·)] ≡ 2
b Tn (m, b)/B and variances V ar[Tn (m, ·)] ≡
b (Tn (m, b)−E[Tn (m, ·)]) /B
of the B bootstrap test statistics Tn (m, b) (i.e., row means and variances
of the matrix Tn ), to yield estimates of E[Tn (m)] and V ar[Tn (m)], respectively, m = 1, . . . , M .


4. Obtain an M × B matrix, Zn ≡ Zn (m, b) , of null value shifted and
scaled bootstrap statistics Zn (m, b), as in Equation (10), by row-shifting
and scaling the matrix Tn using the bootstrap estimates of E[Tn (m)] and
V ar[Tn (m)] and the user-supplied null values λ0 (m) and τ0 (m). That
is,


τ0 (m)
Tn (m, b)+λ0 (m)−E[Tn (m, ·)] .
Zn (m, b) ≡ min 1,
V ar[Tn (m, ·)]
(14)
5. The bootstrap estimate Q0n of the null distribution Q0 from Equation
(10) is the empirical distribution of the B columns Zn (·, b) of matrix
Zn .
Procedure 3 [Bootstrap estimation of common cut-oﬀs and adjusted
p-values for single-step maxT Procedure 1]
14
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0. Apply Procedure 2 to generate an M × B matrix, Zn = Zn (m, b) , of
null value shifted and scaled bootstrap statistics Zn (m, b).
1. Compute the maximum statistic, maxm Zn (m, b), b = 1, . . . , B, for each
bootstrap dataset Xnb , i.e., each column of the matrix Zn .
2. For controlling the FWER at nominal level α ∈ [0, 1], the bootstrap
single-step maxT common cut-oﬀ c(Q0n , α) is the (1 − α)–quantile of
the empirical distribution of the B maxima {maxm Zn (m, b) : b =
1, . . . , B}.
3. The bootstrap single-step maxT adjusted p-value for null hypothesis
H0 (m) is the proportion of maxima {maxm Zn (m, b) : b = 1, . . . , B}
exceeding the corresponding observed test statistic Tn (m),
B
1 

I(max Zn (m, b) ≥ Tn (m)),
P0n (m) ≡
m
B b=1

m = 1, . . . , M. (15)

Note that Procedure 3 could be applied, as in Section 3, below, to any
matrix Zn of resampled statistics (e.g., from other bootstrap or permutation
procedures).

3

Simulation studies

This section presents two separate simulation studies comparing our general
non-parametric bootstrap test statistics null distribution (Procedure 2; Dudoit and van der Laan (2005); Dudoit et al. (2004b); Pollard and van der
Laan (2004); van der Laan et al. (2004b)) to parameter-speciﬁc bootstrap
null distributions proposed in Westfall and Young (1993). Speciﬁcally, the
ﬁrst simulation study considers tests for regression parameters in linear models where the error term is allowed to depend on the covariates and compares
the bootstrap null distribution of Procedure 2 to a bootstrap null distribution which involves resampling residuals (Westfall and Young (1993), Section
3.4.1, p. 106–109). The second simulation study considers tests for correlation coeﬃcients and compares the bootstrap null distribution of Procedure
2 to a bootstrap null distribution which involves resampling individual variables independently (Westfall and Young (1993), Section 6.3, p. 194). For
both testing problems and each null distribution, the resampling version,
15
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in Procedure 3, of single-step maxT Procedure 1, is applied to control the
family-wise error rate.
As detailed in Sections 3.1.4 and 3.2.4, the simulation results demonstrate
that the choice of null distribution can have a substantial impact on the Type
I error and power properties of a given multiple testing procedure, such as the
single-step maxT MTP. The general non-parametric bootstrap test statistics
null distribution of Procedure 2 typically controls the Type I error rate “on
target” at the nominal level α. In contrast, bootstrapping residuals for the
test of regression parameters can lead to severely anti-conservative procedures, while the independent bootstrap for the test of correlation coeﬃcients
can lead to conservative procedures.

3.1

Simulation Study 1: Tests of linear regression coeﬃcients in models with dependent covariates and
error terms

The ﬁrst simulation study concerns tests for regression parameters in linear
models where the error term is allowed to depend on the covariates. This represents an important and practical testing scenario, since in many biomedical
applications, error terms and covariates cannot be assumed to be independent and may have an unknown and complex joint distribution (e.g., logistic
model relating cancer status to miRNA expression measures in Section 4).
3.1.1

Simulation model

Data generating distribution. Consider a data structure (X, Y ) ∼ P ,
where X is an M –dimensional covariate vector and Y a univariate outcome.
Assume that the pair (X, Y ) has an (M + 1)–dimensional Gaussian distribution P , that satisﬁes
E[X] = 0,
E[Y |X] = Xψ,

Cov[X] = σxx ,
V ar[Y |X] = σy|x = s(X),

(16)

where ψ is an M –dimensional vector of regression parameters, σxx an M ×M
covariance matrix, and s(X) a scalar function of the covariates X. That is,
one can express the outcome Y in terms of the familiar linear regression
model
Y = Xψ + ,
where
|X ∼ N(0, s(X)),
(17)
16
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so that,
Y |X ∼ N(Xψ, s(X)).
Suppose one has a random sample X Y n ≡ {(Xi , Yi ) : i = 1, . . . , n}, of n
independent and identically distributed pairs (Xi , Yi ) ∼ P , from the above
speciﬁed Gaussian data generating distribution P . Let Xn and Yn denote,
respectively, the n × M design matrix and the n × 1 outcome vector.
Null and alternative hypotheses. The hypotheses of interest concern the
M components of the regression parameter vector ψ. Speciﬁcally, consider
two-sided tests of the M null hypotheses H0 (m) = I(ψ(m) = ψ0 (m)) vs.
the alternative hypotheses H1 (m) = I(ψ(m) = ψ0 (m)), m = 1, . . . , M . For
simplicity, set the null values ψ0 (m) equal to zero, i.e., ψ0 (m) ≡ 0.
3.1.2

Multiple testing procedures

Test statistics. The M null hypotheses are tested based on standard tstatistics for ordinary least squares (OLS) regression,
Tn (m) ≡

ψn (m)
,
σn (m)

m = 1, . . . , M,

(18)

where ψn = (ψn (m) : m = 1, . . . , M ) is an M –vector of least squares estimators for the regression parameters, with estimated M × M covariance matrix
σn ,
−1 
ψn ≡ (X
n Xn ) Xn Yn ,
(Yn − Xn ψn ) (Yn − Xn ψn ) 
σn ≡
(Xn Xn )−1 .
n−M

(19)

Deﬁne an n–vector en of residuals by
en ≡ Yn − Xn ψn = (ei ≡ Yi − Xi ψn : i = 1, . . . , n).

(20)

The simulation study compares the Type I error and power properties of
FWER-controlling single-step maxT Procedure 1, based on the following two
diﬀerent bootstrap test statistics null distributions (B = 10, 000 bootstrap
samples).

17
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Bootstrap XY null distribution — Bootstrapping covariate/outcome
pairs (X, Y ). The general non-parametric bootstrap test statistics null distribution of Procedure 2 involves resampling covariate/outcome pairs (Xi , Yi )
and computing null value shifted and scaled test statistics for each bootstrap
sample. Speciﬁcally, one proceeds as follows for the bth bootstrap sample,
b = 1, . . . , B.
1. Sample n covariate/outcome pairs (Xib , Yib ) at random, with replacement from the set of n observations X Y n = {(Xi , Yi ) : i = 1, . . . , n}.
Let X Y bn ≡ {(Xib , Yib ) : i = 1, . . . , n} denote the resulting bootstrap
dataset.
2. Compute an M –vector Tn (·, b) = (Tn (m, b) : m = 1, . . . , M ) of bootstrap test statistics as in Equation (18), based on the bootstrap dataset
X Y bn .
3. Compute an M –vector Zn (·, b) = (Zn (m, b) : m = 1, . . . , M ) of bootstrap null value shifted and scaled test statistics,


1
Zn (m, b) ≡ min 1,
Tn (m, b) − E[Tn (m, ·)] ,
V ar[Tn (m, ·)]


where E[Tn (m, ·)] ≡ b Tn (m, b)/B and V ar[Tn (m, ·)] ≡ b (Tn (m, b)−
E[Tn (m, ·)])2 /B denote, respectively, the empirical mean and variance
of the B bootstrap test statistics Tn (m, b) for null hypothesis H0 (m),
m = 1, . . . , M (i.e., row means and variances of the matrix Tn , as in
Procedure 2).
The test statistics null distribution is the empirical distribution Q0n of the
B = 10, 000 M –vectors {Zn (·, b) : b = 1, . . . , B}, i.e., of the columns of matrix Zn .
Bootstrap e null distribution — Bootstrapping residuals e. In contrast, the parameter-speciﬁc bootstrap test statistics null distribution proposed in Section 3.4.1, p. 106–109, of Westfall and Young (1993), involves
resampling residuals ei and computing raw test statistics (without shifting
and scaling) for each bootstrap sample. Speciﬁcally, one proceeds as follows
for the bth bootstrap sample, b = 1, . . . , B.

18
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1. Sample n residuals at random, with replacement from the set of n
observed residuals {ei : i = 1, . . . , n} deﬁned in Equation (20). Let
ebn = (ebi : i = 1, . . . , n) denote the resulting n–vector of bootstrap
residuals.
2. Generate n bootstrap covariate/outcome pairs, by randomly pairing
each of the n observed covariate vectors Xi with a bootstrap residual
ebi , that is, by deﬁning a bootstrap outcome n–vector Ynb ≡ ebn as the
vector of bootstrap residuals. Let X Y bn ≡ {(Xi , Yib ) : i = 1, . . . , n}
denote the resulting bootstrap dataset.
3. Compute an M –vector Tn (·, b) = (Tn (m, b) : m = 1, . . . , M ) of bootstrap test statistics as in Equation (18), based on the bootstrap dataset
X Y bn .
The test statistics null distribution is the empirical distribution Q0n of the
B = 10, 000 M –vectors {Tn (·, b) : b = 1, . . . , B}, i.e., of the columns of matrix Tn .
Thus, bootstrap procedures Bootstrap XY and Bootstrap e diﬀer in two
key aspects: (i) the (re)sampling units: Bootstrap XY resamples covariate/outcome pairs (Xi , Yi ), while Bootstrap e resamples residuals ei ; (ii) the
bootstrap test statistics: Bootstrap XY relies on null value shifted and scaled
test statistics Zn , while Bootstrap e relies on “raw” test statistics Tn . In other
words, procedure Bootstrap e derives the test statistics null distribution by
ﬁrst creating a data generating null distribution in (i), that corresponds to
the complete null hypothesis that the outcome Y is independent of each
covariate X(j). Note that bootstrapping covariate/outcome pairs (Xi , Yi )
preserves the correlation structure of the data, while bootstrapping residuals
and randomly pairing residuals and covariates destroys this correlation.
Single-step maxT procedure. Adjusted p-values for single-step maxT
Procedure 1 may be obtained by applying Procedure 3 with bootstrap null
distributions Bootstrap XY and Bootstrap e. Speciﬁcally, adjusted p-values
for Bootstrap XY and Bootstrap e, are computed, respectively, from the empirical distributions of the B maxima of shifted and scaled test statistics
{maxm Zn (m, b) : b = 1, . . . , B} and raw test statistics {maxm Tn (m, b) : b =
1, . . . , B}. For a test at nominal FWER level α, one rejects null hypotheses
with adjusted p-values less than or equal to α.
19
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3.1.3

Simulation study design

Simulation parameters. The following model parameters are varied in the
simulation study.
• Sample size, n. n = 25, 100.
• Number of hypotheses, M . M = 10, 20.
• Covariance matrix of the covariates, σxx . The covariance matrix σxx
of the covariates has unit diagonal elements and oﬀ-diagonal elements
set to a common value ς, i.e., σxx (j, j) = 1, for j = 1, . . . , J, and
σxx (j, j  ) = ς, for j = j  = 1, . . . , J. The following values are considered
for the common covariance: ς = 0.10, 0.50, 0.80.
• Conditional variance
of outcome Y given covariates X, s(X). V ar[Y |X] =

σy|x = s(X) = m∈H
/ 0 X(m).
• Proportion of true null hypotheses,

h0 h0
. M
M

= 0.50, 0.75.

• Alternative regression parameters, (ψ(m) : m ∈
/ H0 ). For each simulation model, regression parameters (ψ(m) : m ∈
/ H0 ), for the false
null hypotheses, are generated as |H0c | = M − h0 independent uniform
i.i.d.
random variables over the interval [0, √µn ]. That is, ψ(m) ∼ U (0, √µn ),
m ∈
/ H0 . The following values are considered for the magnitude parameter: µ = 0.10, 0.25.
Estimating Type I error rate and power. For each simulation model
(i.e., each combination of parameter values n, M , ς, s(X), h0 /M , and µ),
generate A = 500 random samples, X Y an ≡ {(Xia , Yia ) : i = 1, . . . , n}, of
covariate/outcome pairs (X, Y ) ∼ P . For each such simulated dataset, coma
(m) for single-step maxT Procedure 3, based on
pute adjusted p-values P0n
each of the two bootstrap null distributions (Bootstrap XY and Bootstrap e).
For a given nominal Type I error level α, compute the numbers of rejected
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hypotheses Rna (α), Type I errors Vna (α), and Type II errors Una (α),
Rna (α)

≡

M


a
I(P0n
(m) ≤ α),

(21)

m=1

Vna (α) ≡



a
I(P0n
(m) ≤ α),

m∈H0

Una (α) ≡



a
I(P0n
(m) > α).

m∈H
/ 0

The actual Type I error rate is estimated as follows and then compared to
the nominal Type I error level α,
1
I(Vna (α) > 0).
F W ER(α) ≡
A a=1
A

(22)

The average power of a given MTP is estimated by
1 1 a
U (α).
h1 A a=1 n
A

AvgP wr(α) ≡ 1 −

(23)

The simulation
error
√
√ for the actual Type I error rate and power is of the
order 1/ A = 1/ 500 ≈ 0.045.
Graphical summaries. Simulation results are displayed using the following
two main types of graphical summaries.
• Type I error control comparison. For a given data generating
model, plot, for each MTP, the diﬀerence between the nominal and
actual Type I error rates vs. the nominal Type I error rate, i.e., plot
(α − F W ER(α))

vs.

α,

for α ∈ {0, 0.01, 0.02, . . . , 0.50}, i.e., values of α in seq(from = 0,
to = 0.50, by=0.01). Positive (negative) diﬀerences correspond to
(anti-)conservative MTPs; the higher the curve, the more conservative
the procedure.
• Power comparison. For a given data generating model, receiver operator characteristic (ROC) curves, comparing diﬀerent MTPs in terms
21
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of power, can be obtained by plotting, for each MTP, power vs. actual
Type I error rate, i.e., AvgP wr(α) vs. F W ER(α), for a range of nominal Type I error levels α. However, due to possibly large variations in
power between simulation models, consider instead the following modiﬁed display, which facilitates comparisons across models. For a given
model, plot the diﬀerence in power between two procedures vs. the
actual Type I error rate, i.e., plot
(AvgP wrBoot

XY

(α) − AvgP wrBoot e (α))

vs.

F W ER(α),

for α ∈ {0, 0.01, 0.02, . . . , 0.50}.
3.1.4

Simulation results

Our comparison of the test statistics null distributions Bootstrap XY and
Bootstrap e focusses on Type I error control.
Figure 1 displays diﬀerences between nominal and actual Type I error
rates for four simulation models, where one parameter is varied as the others
remain constant. In general, procedures based on the residual bootstrap
null distribution Bootstrap e are anti-conservative over the entire range of
the nominal level α, while procedures based on the general non-parametric
bootstrap null distribution Bootstrap XY control the Type I error rate at the
target nominal level α. In some testing scenarios, the actual Type I error
rate for Bootstrap e exceeds the nominal Type I error level by as much as
0.20. We comment on a number of trends below.
• Covariance matrix of the covariates, σxx . (Figure 1, Panels (b) vs.
(a)) As the correlation ς between covariates increases, the actual Type
I error rate for Bootstrap XY gets closer to the nominal level α. In
contrast, procedure Bootstrap e becomes more anti-conservative as the
correlation ς increases.
• Sample size, n. (Figure 1, Panels (c) vs. (a)) As the number of observations n increases, the actual Type I error rate for Bootstrap XY gets
closer to the nominal level α.
• Alternative regression parameters, (ψ(m) : m ∈
/ H0 ). (Figure 1, Panels (d) vs. (a)) As the magnitude of the parameter µ, deﬁning the
regression coeﬃcients (ψ(m) : m ∈
/ H0 ) for the false null hypotheses,
22
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increases, the actual Type I error rate for Bootstrap XY gets closer to
the nominal level α. In contrast, procedure Bootstrap e becomes more
anti-conservative as the magnitude µ increases.
• Proportion of true null hypotheses, hM0 . No clear trends are noticeable
for the proportion of true null hypotheses.
We ﬁnd that, for most simulation models,
in power are
√ the diﬀerences
√
within simulation error (i.e., less than 1/ A = 1/ 500 ≈ 0.045), for the
two versions of bootstrap-based single-step maxT Procedure 3 (Figure 2).
Procedure Bootstrap e tends to be slightly more powerful than Bootstrap XY,
especially for the larger correlation value ς = 0.80. The main noticeable
trends are, as expected, that power increases with sample size n and eﬀect
size µ.

3.2

Simulation Study 2: Tests of correlation coeﬃcients

The second simulation study concerns tests of correlation coeﬃcients, a testing scenario of great interest in genomic applications. Indeed, as illustrated
in Section 4, below, a common question is the identiﬁcation of genes with
correlated expression proﬁles in microarray and other high-throughput gene
expression assays.
3.2.1

Simulation model

Data generating distribution. Consider a random J–vector X ∼ P =
N(0, σ), with J–dimensional Gaussian distribution P , mean vector zero, and
covariance matrix σ = (σ(j, j  ) : j, j  = 1, . . . , J) equal to the corresponding
correlation matrix ρ = (ρ(j, j  ) : j, j  = 1, . . . , J).
Suppose one has a random sample Xn ≡ {Xi : i = 1, . . . , n}, of n i.i.d.
random variables Xi ∼ P , from the above speciﬁed Gaussian data generating
distribution P .
Null and
J  alternative hypotheses. The hypotheses of interest concern the
M ≡ 2 = J(J − 1)/2 distinct entries ψ = (ψ(m) : m = 1, . . . , M ) of the
J × J correlation matrix ρ. One may recode pairs of row and column indices
{(j, j  ) : j = 1, . . . , (J − 1), j  = j + 1, . . . , J}, for the upper triangle of ρ,
into a single index m = 1, . . . , M , deﬁned by m ≡ (j − 1)(2J − j)/2 + (j  − j).
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Consider two-sided tests of the M = J(J − 1)/2 null hypotheses H0 (m) =
I(ψ(m) = ψ0 (m)) vs. the alternative hypotheses H1 (m) = I(ψ(m) = ψ0 (m)),
m = 1, . . . , M . For simplicity, set the null values ψ0 (m) equal to zero, i.e.,
test the null hypotheses of no correlation.
3.2.2

Multiple testing procedures

Test statistics. The M null hypotheses are tested based on the following
t-statistics,
Tn (m) ≡

√

ψn (m)

n − 2

1 − ψn2 (m)

,

m = 1, . . . , M,

(24)

where ψn = (ψn (m) : m = 1, . . . , M ) is the M –vector of empirical correlation
coeﬃcients. Speciﬁcally, the empirical correlation coeﬃcient for the pair of
random variables (X(j), X(j  )), corresponding to the mth null hypothesis, is
deﬁned as
σn (j, j  )
,
(25)
ψn (m) = ρn (j, j  ) ≡ 
σn (j, j)σn (j  , j  )
based on empirical means X̄n (j) and covariances σn (j, j  ),
1
Xi (j),
X̄n (j) ≡
n i=1
n

1
σn (j, j ) ≡
(Xi (j) − X̄n (j))(Xi (j  ) − X̄n (j  )).
n i=1
n



For Gaussian data generating distributions, the t-statistics in Equation (24)
have marginal t-distributions with (n − 2) degrees of freedom, under the
null hypotheses that the corresponding correlation coeﬃcients are zero, i.e.,
ψ(m) = 0 (with the ﬁnite sample bias correction n/(n − 1) in the deﬁnition
of the empirical covariance matrix σn ).
One could also use unstandardized test statistics,
√
m = 1, . . . , M.
(26)
Tn (m) ≡ nψn (m),
The simulation study compares the Type I error and power properties of
FWER-controlling single-step maxT Procedure 1, based on the following two
diﬀerent bootstrap test statistics null distributions (B = 10, 000 bootstrap
samples).
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Bootstrap X null distribution — Bootstrapping entire J–vectors X.
The general non-parametric bootstrap test statistics null distribution of Procedure 2 involves resampling entire J–vectors Xi and computing null value
shifted and scaled test statistics for each bootstrap sample. Speciﬁcally, one
proceeds as follows for the bth bootstrap sample, b = 1, . . . , B.
1. Sample n J–vectors Xib at random, with replacement from the set of n
observations Xn = {Xi : i = 1, . . . , n}. Let Xnb ≡ {Xib : i = 1, . . . , n}
denote the resulting bootstrap dataset.
2. Compute an M –vector Tn (·, b) = (Tn (m, b) : m = 1, . . . , M ) of bootstrap test statistics as in Equation (24), based on the bootstrap dataset
Xnb .
3. Compute an M –vector Zn (·, b) = (Zn (m, b) : m = 1, . . . , M ) of bootstrap null value shifted and scaled test statistics,


1
Tn (m, b) − E[Tn (m, ·)] ,
Zn (m, b) ≡ min 1,
V ar[Tn (m, ·)]


where E[Tn (m, ·)] ≡ b Tn (m, b)/B and V ar[Tn (m, ·)] ≡ b (Tn (m, b)−
E[Tn (m, ·)])2 /B denote, respectively, the empirical mean and variance
of the B bootstrap test statistics Tn (m, b) for null hypothesis H0 (m),
m = 1, . . . , M (i.e., row means and variances of the matrix Tn , as in
Procedure 2).
The test statistics null distribution is the empirical distribution Q0n of the
B = 10, 000 M –vectors {Zn (·, b) : b = 1, . . . , B}, i.e., of the columns of matrix Zn .
Bootstrap X(j) null distribution — Bootstrapping independent entries X(j) of the J–vectors X. In contrast, the parameter-speciﬁc bootstrap test statistics null distribution proposed in Section 6.3, p. 194, of
Westfall and Young (1993), involves resampling each component Xi (j) of the
J–vectors Xi independently and computing raw test statistics (without shifting and scaling) for each bootstrap sample. Speciﬁcally, one proceeds as
follows for the bth bootstrap sample, b = 1, . . . , B.
1. For each variable X(j), j = 1, . . . , J, sample n j–speciﬁc entries Xib (j),
i = 1, . . . , n, at random, with replacement from the set of n j–speciﬁc
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observations {Xi (j) : i = 1, . . . , n}. The ith bootstrap J–vector Xib =
(Xib (j) : j = 1, . . . , J), i = 1, . . . , n, is obtained by combining J such
independently sampled variables. Let Xnb ≡ {Xib : i = 1, . . . , n} denote
the resulting bootstrap dataset.
2. Compute an M –vector Tn (·, b) = (Tn (m, b) : m = 1, . . . , M ) of bootstrap test statistics as in Equation (24), based on the bootstrap dataset
Xnb .
The test statistics null distribution is the empirical distribution Q0n of the
B = 10, 000 M –vectors {Tn (·, b) : b = 1, . . . , B}, i.e., of the columns of matrix Tn .
As in the regression example of Section 3.1, bootstrap procedures Bootstrap X and Bootstrap X(j) diﬀer in two key aspects: (i) the (re)sampling
units: Bootstrap X resamples entire J–vectors Xi , while Bootstrap X(j) resamples independent components Xi (j); (ii) the bootstrap test statistics:
Bootstrap X relies on null value shifted and scaled test statistics Zn , while
Bootstrap X(j) relies on “raw” test statistics Tn . In other words, procedure
Bootstrap X(j) derives the test statistics null distribution by ﬁrst creating a
data generating null distribution in (i), that corresponds to the complete null
hypothesis that the J variables X(j), j = 1, . . . , J, are independent.
Single-step maxT procedure. Adjusted p-values for single-step maxT
Procedure 1 may be obtained by applying Procedure 3 with bootstrap null
distributions Bootstrap X and Bootstrap X(j). Speciﬁcally, adjusted p-values
for Bootstrap X and Bootstrap X(j), are computed, respectively, from the
empirical distributions of the B maxima of shifted and scaled test statistics
{maxm Zn (m, b) : b = 1, . . . , B} and raw test statistics {maxm Tn (m, b) : b =
1, . . . , B}. For a test at nominal FWER level α, one rejects null hypotheses
with adjusted p-values less than or equal to α.
3.2.3

Simulation study design

Simulation parameters. The following model parameters are used in the
simulation study.
• Sample size, n. n = 25.
• Number of hypotheses, M . M = 45.
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• Proportion of true null hypotheses,

h0 h0
. M
M

=

25
45

≈ 0.56.

• Correlation matrix, ρ. The correlation matrix ρ = (ρ(j, j  ) : j, j  =
1, . . . , J) (here, equal to the covariance matrix σ) has the following
block diagonal form,


J/2×J/2 OJ/2×J/2
,
(27)
ρ=
OJ/2×J/2
J/2×J/2
where OJ/2×J/2 denotes a J/2 × J/2 matrix of zeros and J/2×J/2 a
J/2×J/2 matrix with unit diagonal elements and oﬀ-diagonal elements
set to a common value , i.e., J/2×J/2 (j, j) = 1, for j = 1, . . . , J/2,
and J/2×J/2 (j, j  ) = , for j = j  = 1, . . . , J/2. The following values are considered for the common block correlation coeﬃcient: =
0.30, 0.50, 0.60.
Note that the only parameter that is varied in the simulation study is
the correlation matrix, ρ, that is, the parameter of interest in the multiple
testing problem.
Estimating Type I error rate and power. As in Section 3.1.3, above,
for Simulation Study 1.
Graphical summaries. As in Section 3.1.3, above, for Simulation Study 1.

3.2.4

Simulation results

Our comparison of the test statistics null distributions Bootstrap X and Bootstrap X(j) focusses on Type I error rate control.
Figure 3 displays diﬀerences between nominal and actual Type I error
rates for three simulation models, where the common block correlation coeﬃcient is varied as the other parameters remain constant. In general,
procedures based on the independent covariates bootstrap null distribution
Bootstrap X(j) are conservative over the entire range of the nominal level α,
while procedures based on the general non-parametric bootstrap null distribution Bootstrap X control the Type I error rate closer to the target nominal
level α. The most extreme diﬀerences are observed for large nominal Type I
error levels α. In some testing scenarios, the nominal level for Bootstrap X(j)
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exceeds the actual Type I error rate by as much as 0.25. As the correlation
parameter increases, procedure Bootstrap X(j) becomes more conservative.
As in the ﬁrst simulation study, we ﬁnd that, for most simulation models,
√
the√diﬀerences in power are within simulation error (i.e., less than 1/ A =
1/ 500 ≈ 0.045), for the two versions of bootstrap-based single-step maxT
Procedure 3 (Figure 4). Procedure Bootstrap X tends to be slightly more
powerful than Bootstrap X(j), especially for larger correlation parameters
. The main noticeable trends are, as expected, that power increases with
sample size n and eﬀect size .
Similar trends are observed for standardized (Equation (24)) and unstandardized (Equation (26)) correlation test statistics (data not shown for
unstandardized statistics).

4

microRNA data analysis

In addition to playing the important role of passing genetic messages from
DNA to the protein-making machinery of the cell, RNA serves many other
cellular functions. A new class of small, non-coding RNAs, known as microRNAs (miRNA), are currently the subject of intense study due to their
provocative roles in controlling developmental timing and regulating the
translation of messenger RNA (mRNA). Like transcription factor proteins,
miRNAs have the potential to aﬀect the abundance of a wide range of proteins in the cell. In their recent article, investigating miRNA levels in cells
derived from cancerous and non-cancerous tissues, Lu et al. (2005) made an
astonishing discovery: predictors based on abundance of the several hundred
known mammalian miRNAs are better able to distinguish developmental lineage, diﬀerentiation state, and cancer state, than the best predictors based
on genome-wide mRNA expression proﬁles from the same cells. Motivated by
these ﬁndings, we have undertaken further analysis of this publicly available
miRNA dataset.

4.1

miRNA dataset of Lu et al. (2005)

Lu et al. (2005) measured expression levels of 217 known human miRNAs,
by a bead-based ﬂow cytometric proﬁling method, in cells from 46 cancerous
and 140 healthy tissues (n = 186 total samples). The pre-processed, log2 transformed data are available from the authors’ website (www.broad.mit.
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edu/cancer/pub/miGCM: miRNA expression measures in ﬁle miGCM 218.gct;
probe sequence information in ﬁle supplementary table 1.xls; target sample information, such as cancer status and tissue type, in ﬁle supplementary table 2.xls).
The analyses in Sections 4.2 and 4.3, below, exclude cell lines and any miRNA
with expression measures below a detection threshold of log2 (32) = 5 in more
than half of the n = 186 samples.
The data for each of the n = 186 samples consist of a binary outcome
Yi for cancer status (1 for cancerous vs. 0 for healthy tissues) and a J =
155–dimensional covariate vector Xi = (Xi (j) : j = 1, . . . , J) of real-valued
expression measures for each of J = 155 miRNAs, i = 1, . . . , n.

4.2

Tests of logistic regression coeﬃcients: Diﬀerentially expressed miRNAs between cancerous and
healthy tissues

The original publication of Lu et al. (2005) includes a comparison of miRNA
expression measures between cancerous and healthy tissues, using the FWERcontrolling marginal Bonferroni procedure, with modiﬁed two-sample t-statistics.
For a test at nominal FWER level α = 0.05, the authors found that 59% of the
miRNAs were signiﬁcantly less abundant in cancerous compared to healthy
tissues. Only a few miRNAs were over-expressed in cancerous tissues and
none signiﬁcantly so. miRNA measures were observed to vary greatly among
the 19 diﬀerent tissue types represented in the dataset (stomach, colon, pancreas, etc.); tissue type was therefore treated as a confounding variable.
Multiple testing procedure. An alternative approach to identifying differentially expressed miRNAs between cancerous and healthy tissues is to
ﬁt, for each miRNA, a logistic regression model including tissue type as a
covariate. Speciﬁcally, the logistic regression model for the jth miRNA is
logit(E[Y |X]) ≡ α(j) + β(j)X(j) + γ(j)W,

j = 1, . . . , J,

(28)

where logit(z) ≡ log(z/(1 − z)) is the logit function, W is a 19–dimensional
tissue type indicator vector, and γ(j) a corresponding miRNA-speciﬁc 19–
dimensional parameter vector.
The parameter of interest in the logistic model of Equation (28) is β(j),
the scalar coeﬃcient for the expression measure X(j) of the jth miRNA,
j = 1, . . . , J. Thus, for each miRNA, one considers two-sided tests of the
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null hypotheses H0 (j) = I(β(j) = 0), of no association of the expression
measures X(j) with cancer status Y , vs. the alternative hypotheses H1 (j) =
I(β(j) = 0). Two-sided tests are used to identify both over- and underexpressed miRNAs in cancerous tissues.
The J null hypotheses are tested based on the following t-statistics,
Tn (j) ≡

βn (j) − β0 (j)
,
σn (j)

j = 1, . . . , J,

(29)

where the null values β0 (j) are zero and βn (j) are logistic regression parameter estimates with estimated standard errors σn (j) (as implemented in the R
function glm for the binomial family, with the call glm(Y ~ X(j) + W, family="binomial")).
In order to simultaneously test the J null hypotheses of no association of
miRNA measures with cancer status, we apply FWER-controlling single-step
maxT Procedure 1, with the general non-parametric bootstrap test statistics
null distribution of Procedure 2 (B = 5, 000 bootstrap samples). That is,
test statistic cut-oﬀs and adjusted p-values are computed as in Procedure 3.
Note that ﬁtting the logistic regression model of Equation (28) allows the
identiﬁcation of diﬀerentially expressed miRNAs, while adjusting for tissue
type.
Results. Bootstrap-based single-step maxT Procedure 3 yields 102 miRNAs (66% of the 155 studied) with adjusted p-values less than a nominal
FWER level α = 0.05. In fact, 53 of the p-values are less than 0.01 and
36 are approximately equal to zero, indicating that some miRNAs are very
signiﬁcantly diﬀerentially expressed between cancerous and healthy tissues
(Table 2 and Figure 5). All of the 102 signiﬁcant miRNAs have test statistics
Tn (j) < −3.6, suggesting under-expression in cancerous compared to healthy
tissues. These ﬁndings are in agreement with the original publication of Lu
et al. (2005), but a larger proportion of the studied miRNAs are found to be
signiﬁcantly diﬀerentially expressed with our proposed bootstrap method.
Five of the highly signiﬁcant miRNAs listed in Table 2 are located in
minimal deleted regions, minimal ampliﬁed regions, and breakpoint regions
involved in human cancers (Calin et al., 2004). Speciﬁcally, miR-23b and
let-7d have been associated with urothelial cancer, miR-100 with breast,
lung, ovarian, and cervical cancers, miR-22 with hepatocellular cancer, and
miR99a with lung cancer.
Note that another approach for comparing mean miRNA expression measures in cancerous vs. healthy tissues could be based on standard two-sample
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t-statistics. For such simple tests, data generating null distributions, such as
the permutation distribution, lead to proper Type I error control under the
conditions that (i) the two populations have the same covariance matrices or
(ii) the two sample sizes are equal (Pollard and van der Laan, 2004). Our
general multiple testing methodology, however, allows one to use more general and ﬂexible models, such as the logistic regression model of Equation
(28), which facilitates adjustment for covariates and also provides a simple
predictor of cancer status.

4.3

Tests of correlation coeﬃcients: Co-expressed miRNAs

A biological question of great interest in gene expression experiments is the
identiﬁcation of co-expressed genes, here, miRNAs with correlated expression measures across tissue samples. While some tests of association between
miRNA abundance and a binary outcome, such as cancer status, could be
performed with standard multiple testing tools (e.g., MTPs based on a permutation data generating null distribution), correlation tests are a case where
our bootstrap-based MTPs truly allow one to perform previously unavailable
analyses.
Multiple testing procedures. Consider, the M ≡ J(J − 1)/2 = 155 ×
154/2 = 11, 935 distinct Pearson correlation coeﬃcients between pairs of
miRNA expression proﬁles,
ρ(j, k) ≡ Cor[X(j), X(k)],

j = 1, . . . , J − 1, k = j + 1, . . . , J.

(30)

It is of interest to identify all pairs of miRNAs with signiﬁcantly correlated expression proﬁles across the n = 186 samples. Thus, for each distinct
pair (j, k) of miRNAs, one considers two-sided tests of the null hypotheses
H0 (j, k) = I(ρ(j, k) = 0), of no association in expression measures, vs. the
alternative hypotheses H1 (j, k) = I(ρ(j, k) = 0).
The M null hypotheses are tested based on the following test statistics,
√
j = 1, . . . , J − 1, k = j + 1, . . . , J,
(31)
Tn (j, k) ≡ nρn (j, k),
where ρn (j, k) are empirical correlation coeﬃcients, as deﬁned previously in
Section 3.2.2.
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In order to simultaneously test the M = 11, 935 null hypotheses of
no association in expression measures between pairs of miRNAs, we again
apply FWER-controlling single-step maxT Procedure 1, with the general
non-parametric bootstrap test statistics null distribution of Procedure 2
(B = 5, 000 bootstrap samples). That is, test statistic cut-oﬀs and adjusted
p-values are computed as in Procedure 3.
Results. Interestingly, bootstrap-based single-step maxT Procedure 3 yields
8,916 miRNA pairs (or nearly 75% of all M = 11, 935 pairs) with adjusted
p-values less than a nominal FWER level α = 0.05 and 7,479 with p-values
approximately equal to zero (Figure 6). Correlations found to be statistically
signiﬁcantly diﬀerent from zero at nominal level α = 0.05 range from 0.26
to 0.99, with median value 0.55. The most signiﬁcant are given in Table 3.
Several pairs are composed of miRNAs in the same family, e.g., hsa-miR-10a
and hsa-miR-10b. Only 8% of all pairwise correlations are negative, and none
are signiﬁcantly so.
The two most signiﬁcantly correlated miRNAs are a pair of paralogs,
miR-17-5p (chromosome 17) and miR-106a (chromosome X), which are part
of miRNA clusters believed to be up-regulated by the proto-oncogene c-MYC
(O’Donnell et al., 2005). miR-19a, miR-19b, and miR-20 are also members
of these paralogous miRNA clusters. Several other co-expressed miRNAs
are linked to cancer. In particular, miR-107 has been shown to increase cell
growth in lung carcinomas (Cheng et al., 2005). miR-143 and miR-145, located within 1.7 kb on human chromosome 5, are expressed at lower levels in
cancerous and pre-cancerous tissue compared to normal colon tissue (Michael
et al., 2003).
Cluster analysis. The above multiple testing analysis clearly suggests the
existence of clusters of highly correlated miRNAs. We therefore decided to
perform hierarchical clustering of the miRNAs, in order to identify general
expression patterns and groups of co-expressed miRNAs. We use the hierarchical ordered partitioning and collapsing hybrid (HOPACH) algorithm with
Pearson correlation distance (van der Laan and Pollard, 2003). Figure 7
displays the 155 × 155 miRNA correlation matrix, ordered according to the
ﬁnal level of the HOPACH tree, so that similarly expressed miRNAs appear
near each other. It will be of great interest to investigate the biological and
medical implications of clusters of co-expressed miRNAs.
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5

Conclusions

This investigation of multiple testing procedures has focused on the choice
of a test statistics null distribution, in testing problems for which subset pivotality does not hold. Subset pivotality is a condition under which data generating distributions satisfying the complete null hypothesis produce valid
test statistics null distributions (Westfall and Young (1993), p. 42–43).
Commonly-used permutation or parameter-speciﬁc bootstrap test statistics
null distributions rely on the subset pivotality condition to justify Type I error control under the true distribution. However, subset pivotality is violated
in many important testing problems, since a data generating null distribution
may result in a joint distribution for the test statistics that has a diﬀerent
dependence structure than their true distribution. In fact, in most situations,
there does not even exist a data generating null distribution that correctly
speciﬁes the joint distribution of the test statistics corresponding to the true
null hypotheses.
Indeed, subset pivotality fails for two types of testing problems that are
highly relevant in biomedical and genomic data analysis: tests concerning
correlation coeﬃcients and tests concerning regression parameters. Correlation tests abound in molecular biology, where similarities between measurable properties of large numbers of genes and genome sequences are of
great interest. Non-linear regression models are also frequently used to assess
genotype/phenotype associations, while adjusting for potential confounding
variables. Procedures based on a data generating null distribution, such as
a permutation distribution, do not provide a correct test statistics null distribution in these settings.
Motivated by limitations of existing approaches, Pollard and van der Laan
(2004), and subsequently Dudoit et al. (2004b), propose a general characterization and explicit construction of a test statistics null distribution that
controls Type I errors, without requirements such as subset pivotality, in
testing problems involving general data generating distributions (i.e., arbitrary dependence structures among variables). Resampling procedures, such
as the bootstrap procedures of Section 2.4, are provided to conveniently obtain consistent estimators of the null distribution and of the resulting test
statistic cut-oﬀs and adjusted p-values. Pollard and van der Laan (2004)
compare MTPs based on the proposed bootstrap test statistics null distribution and several other null distributions in the two-sample testing problem.
The former null distribution performs competitively whenever the sample
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sizes are large enough to avoid ties in the resampled distribution and poorly
estimated variances in the denominators of t-statistics.
The goal of the present paper was to evaluate the practical performance
of diﬀerent test statistics null distributions in cases where subset pivotality
fails. Speciﬁcally, the simulation studies of Section 3 compare our general
non-parametric bootstrap test statistics null distribution (Procedure 2) to
parameter-speciﬁc bootstrap null distributions, in the following two settings:
tests for regression coeﬃcients in linear models where covariates and error
terms are allowed to be dependent and tests for correlation coeﬃcients. The
general non-parametric bootstrap distribution (Procedure 2, Bootstrap XY
and Bootstrap X) diﬀers from corresponding parameter-speciﬁc bootstrap
distributions (Bootstrap e and Bootstrap X(j)) in two key aspects: (i) the
(re)sampling units: Bootstrap XY and Bootstrap X resample “raw” observations, while Bootstrap e and Bootstrap X(j) resample, respectively, residuals ei
and independent components Xi (j); (ii) the bootstrap test statistics: Bootstrap XY and Bootstrap X rely on null value shifted and scaled test statistics
Zn , while Bootstrap e and Bootstrap X(j) rely on “raw” test statistics Tn .
In other words, procedures Bootstrap e and Bootstrap X(j) derive the test
statistics null distribution by ﬁrst creating a data generating distribution
that satisﬁes the complete null hypothesis.
The simulation studies, involving a range of data generating models,
demonstrate that the choice of null distribution can have a substantial impact
on the Type I error and power properties of a given multiple testing procedure. The single-step maxT procedure, based on the general non-parametric
bootstrap null distribution of Procedure 2, does indeed control the familywise error rate at or slightly below the target nominal level. Interestingly,
comparable MTPs based on parameter-speciﬁc bootstrap null distributions,
are anti-conservative for tests of regression coeﬃcients (Bootstrap e) and conservative for tests of correlation coeﬃcients (Bootstrap X(j)). Power is similar
for the diﬀerent null distributions in both testing problems.
Section 4 illustrates the ﬂexibility and power of our proposed methodology, by applying the single-step maxT procedure, with general non-parametric
bootstrap test statistics null distribution (Procedures 2 and 3), to a dataset
of miRNA expression measures from cancerous and healthy tissues (Lu et al.,
2005). Tests for regression coeﬃcients, in a logistic model adjusting for tissue type, identify 102 miRNAs as being signiﬁcantly diﬀerentially expressed
between cancerous and healthy tissues (nominal FWER level 0.05). This corroborates the original article’s discovery that miRNA expression proﬁling has
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great potential for cancer diagnosis. Stepwise, augmentation, and empirical
Bayes procedures could be used for more powerful analyses and control of a
broader class of Type I error rates (Dudoit and van der Laan, 2005; Dudoit
et al., 2004a; van der Laan et al., 2005, 2004a,b).
We also investigated several questions not addressed in the original publication of Lu et al. (2005). Firstly, we performed multiple testing to identify
pairs of miRNAs with signiﬁcantly correlated expression proﬁles. The fact
that a majority of pairwise correlations are signiﬁcantly diﬀerent from zero,
even after adjusting for multiple tests (nominal FWER level 0.05), suggests
a great deal of structure in miRNA expression. This prompted us to perform hierarchical clustering of the miRNA proﬁles. The HOPACH algorithm
yielded sensible ordering of the miRNAs, with groups of similarly expressed
miRNAs visualized as blocks in the pseudo-color image of the J ×J (J = 155)
correlation matrix (Figure 7). In order to focus on the most correlated pairs
of miRNAs, the correlation tests could be repeated with a null value larger
than zero, e.g., H0 (j, k) = I(ρ(j, k) ≤ 0.5), j = 1, . . . , J, k = j + 1, . . . , J.
Further investigation of clusters of co-expressed miRNAs could reveal biologically interesting connections between miRNAs.
We note that the large number of signiﬁcant ﬁndings in both miRNA testing problems is likely due to a reasonably large sample size (n = 186) relative
to the number of tests (M = 155 regression coeﬃcients and M = 11, 935 correlation coeﬃcients), as compared to similar studies of mRNA expression.
Nonetheless, the analysis of a rich dataset using novel and rigorous statistical methods highlights the possibility for meaningful biological and medical
discovery from genomic studies.

Software
Our proposed resampling-based multiple testing procedures are implemented
in the R package multtest, released as part of the Bioconductor Project, an
open-source software project for the analysis of biomedical and genomic data
(Pollard et al. (2005); multtest package, Version 1.6.0, Bioconductor Release
1.6, www.bioconductor.org). Birkner et al. (2005b) illustrate the implementation in SAS (Version 9) of the bootstrap-based single-step maxT procedure
and augmentation procedures for controlling the generalized family-wise error rate (gFWER) and tail probabilities for the proportion of false positives
(TPPFP) among the rejected hypotheses.
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The hierarchical ordered partitioning and collapsing hybrid (HOPACH)
algorithm is implemented in the Bioconductor R package hopach (Pollard and
van der Laan (2005); hopach package, Version 1.1.1, Bioconductor Release
1.6).
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Table 1: Type I and Type II errors in multiple hypothesis testing. This
table summarizes the diﬀerent types of decisions and errors in multiple
hypothesis
testing. The number of rejected hypotheses is Rn ≡ |Rn | =
M
I(T
(m)
∈ Cn (m)), the number of Type I errors is Vn ≡ |Rn ∩
n
m=1 
H0 | =
n (m) ∈ Cn (m)), and the number of Type II errors is
m∈H0 I(T
/ Cn (m)).
Un ≡ |Rcn ∩ H1 | = m∈H1 I(Tn (m) ∈
Null hypotheses
not rejected
rejected
true

|Rcn ∩ H0 |

Vn = |Rn ∩ H0 | h0 = |H0 |
(Type I)

Null hypotheses
false Un = |Rcn ∩ H1 |
(Type II)
M − Rn

|Rn ∩ H1 |

h1 = |H1 |

Rn = |Rn |

M
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Figure 1: Simulation Study 1: Tests of linear regression coeﬃcients, Type I
error control comparison. Plots of diﬀerences between nominal and actual
Type I error rates vs. nominal Type I error rate, for single-step maxT procedure based on general non-parametric bootstrap null distribution Bootstrap
XY and residual bootstrap null distribution Bootstrap e. The null hypotheses are tested using the t-statistics of Equation (18). Panel (a): Model with
sample size n = 25; M = 10 null hypotheses; common covariance for the
covariates ς = 0.50; proportion h0 /M = 0.50 of true null hypotheses; magnitude parameter for alternative regression coeﬃcients µ = 0.10. Panel (b):
n = 25; M = 10; ς = 0.80; h0 /M =400.50; µ = 0.10. Panel (c): n = 100;
M = 10; ς = 0.50; h0 /M = 0.50; µ = 0.10. Panel (d): n = 25; M = 10;
ς = 0.50; h0 /M = 0.50; µ = 0.25.
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Figure 2: Simulation Study 1: Tests of linear regression coeﬃcients, power
comparison. Plots of diﬀerence in power vs. actual Type I error rate, for
single-step maxT procedure based on general non-parametric bootstrap null
distribution Bootstrap XY and residual bootstrap null distribution Bootstrap
e. The null hypotheses are tested using the t-statistics of Equation (18).
Positive diﬀerences indicate greater power for Bootstrap XY. Panel (a): Model
with sample size n = 25; M = 10 null hypotheses; common covariance for
the covariates ς = 0.50; proportion h0 /M = 0.50 of true null hypotheses;
magnitude parameter for alternative regression coeﬃcients µ = 0.10. Panel
(b): n = 25; M = 10; ς = 0.80; h0 /M41= 0.50; µ = 0.10. Panel (c): n = 100;
M = 10; ς = 0.50; h0 /M = 0.50; µ = 0.10. Panel (d): n = 25; M = 10;
ς = 0.50; h0 /M = 0.50; µ = 0.25.
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Figure 3: Simulation Study 2: Tests of correlation coeﬃcients, Type I error
control comparison. Plots of diﬀerences between nominal and actual Type
I error rates vs. nominal Type I error rate, for single-step maxT procedure
based general non-parametric bootstrap null distribution Bootstrap X and
independent covariates bootstrap null distribution Bootstrap X(j). The null
hypotheses are tested using the t-statistics of Equation (24). Model with
sample size n = 25; M = 45 null hypotheses; proportion h0 /M = 25/45 of
true null hypotheses. Panel (a): common correlation coeﬃcient for the two
blocks = 0.30. Panel (b): = 0.50. Panel (c): = 0.60.
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Figure 4: Simulation Study 2: Tests of correlation coeﬃcients, power comparison. Plots of diﬀerence in power vs. actual Type I error rate, for single-step
maxT procedure based on general non-parametric bootstrap null distribution
Bootstrap X and independent covariates bootstrap null distribution Bootstrap
X(j). The null hypotheses are tested using the t-statistics of Equation (24).
Positive diﬀerences indicate greater power for Bootstrap X. Model with sample size n = 25; M = 45 null hypotheses; proportion h0 /M = 25/45 of true
null hypotheses. Panel (a): common correlation coeﬃcient for the two blocks
= 0.30. Panel (b): = 0.50. Panel (c): = 0.60.
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Table 2: miRNA data analysis: Tests of logistic regression coeﬃcients. The
table reports the names, target sequences, and test statistics, for the 36
miRNAs most signiﬁcantly diﬀerentially expressed between cancerous and
healthy tissues, according to bootstrap-based single-step maxT Procedure 3.
All 36 miRNAs have adjusted p-values approximately equal to zero. miRNAs
are ordered by test statistic Tn (j), with most signiﬁcant (largest in absolute
value) ﬁrst. Negative test statistics indicate under-expression in cancerous
compared to healthy tissues. The target sequence is the reverse complement of the miRNA sequence, which identiﬁes potential binding sites for the
miRNA.
# Located in minimal deleted regions, minimal ampliﬁed regions, and breakpoint regions involved in human cancers (Calin et al., 2004) .
Name
hsa-miR-98
hsa-miR-28
hsa-miR-196
hsa-miR-30a
hsa-miR-30e
hsa-miR-99a#
rno-miR-335
hsa-let-7e
hsa-miR-23b#
hsa-miR-99b
hsa-miR-214
hsa-miR-30b
hsa-miR-30c
mmu-miR-338
hsa-miR-103
hsa-miR-185
rno-miR-151*
hsa-miR-20 (sub 1)
hsa-miR-100#
hsa-miR-22#
rno-miR-129*
hsa-let-7d#
hsa-miR-107
rno-miR-352
hsa-miR-32
hsa-miR-197
mmu-miR-342
hsa-miR-128b
mmu-miR-324-5p
hsa-miR-126*
hsa-miR-19b
mmu-miR-151 (sub 1)
hsa-let-7i
hsa-miR-199a*
hsa-miR-10b
mmu-miR-292-3p

miRNA target sequence
UGAGGUAGUAAGUUGUAUUGUU
AAGGAGCUCACAGUCUAUUGAG
UAGGUAGUUUCAUGUUGUUGG
CUUUCAGUCGGAUGUUUGCAGC
UGUAAACAUCCUUGACUGGA
AACCCGUAGAUCCGAUCUUGUG
UCAAGAGCAAUAACGAAAAAUGU
UGAGGUAGGAGGUUGUAUAGU
AUCACAUUGCCAGGGAUUACCAC
CACCCGUAGAACCGACCUUGCG
ACAGCAGGCACAGACAGGCAG
UGUAAACAUCCUACACUCAGC
UGUAAACAUCCUACACUCUCAGC
UCCAGCAUCAGUGAUUUUGUUGA
AGCAGCAUUGUACAGGGCUAUGA
UGGAGAGAAAGGCAGUUC
UCGAGGAGCUCACAGUCUAGUA
UAAAGUGCUUAUAGUGCAGGUAG
AACCCGUAGAUCCGAACUUGUG
AAGCUGCCAGUUGAAGAACUGU
AAGCCCUUACCCCAAAAAGCAU
AGAGGUAGUAGGUUGCAUAGU
AGCAGCAUUGUACAGGGCUAUCA
AGAGUAGUAGGUUGCAUAGUA
UAUUGCACAUUACUAAGUUGC
UUCACCACCUUCUCCACCCAGC
UCUCACACAGAAAUCGCACCCGUC
UCACAGUGAACCGGUCUCUUUC
CGCAUCCCCUAGGGCAUUGGUGU
CAUUAUUACUUUUGGUACGCG
UGUGCAAAUCCAUGCAAAACUGA
ACUAGACUGAGGCUCCUUGAGG
UGAGGUAGUAGUUUGUGCU
UACAGUAGUCUGCACAUUGGUU
UACCCUGUAGAACCGAAUUUGU
AAGUGCCGCCAGGUUUUGAGUGU

Test statistic
-4.88
-4.79
-4.79
-4.78
-4.78
-4.77
-4.72
-4.69
-4.67
-4.67
-4.67
-4.66
-4.66
-4.65
-4.64
-4.63
-4.62
-4.61
-4.61
-4.60
-4.60
-4.58
-4.58
-4.58
-4.57
-4.57
-4.56
-4.51
-4.51
-4.50
-4.49
-4.49
-4.48
-4.48
-4.47
-4.46
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Table 3: miRNA data analysis: Tests of correlation coeﬃcients. The table
reports the names and correlation coeﬃcients for the twenty pairs of miRNAs with the most signiﬁcantly correlated expression proﬁles, according to
bootstrap-based single-step maxT Procedure 3. miRNAs are ordered by test
statistic Tn (m), with most signiﬁcant (largest in absolute value) ﬁrst. Several
pairs are composed of miRNAs in the same family, e.g., hsa-miR-10a and
hsa-miR-10b.
# Up-regulated by the proto-oncogene c-MYC (O’Donnell et al., 2005). †
Increases cell growth in lung carcinomas (Cheng et al., 2005). ‡ Expressed at
lower levels in cancerous and pre-cancerous compared to normal colon tissue
(Michael et al., 2003).
Names
hsa-miR-106a# hsa-miR-17-5p#
mmu-miR-200b hsa-miR-200b
mmu-miR-200b hsa-miR-200c
hsa-miR-107† hsa-miR-103
hsa-miR-200b hsa-miR-200c
hsa-miR-145‡ hsa-miR-143‡
hsa-miR-199a (sub 1) mmu-miR-199b
hsa-miR-17-5p hsa-miR-20 (sub 1)
hsa-miR-19a# hsa-miR-19b#
hsa-miR-29a hsa-miR-30a*
hsa-miR-181a hsa-miR-181c
hsa-miR-199a (sub 1) hsa-miR-199a*
hsa-miR-29b (sub 2) hsa-miR-29c
hsa-miR-199a* mmu-miR-199b
hsa-miR-200a hsa-miR-141
hsa-miR-20 (sub 1)# mmu-miR-106a
hsa-miR-106a hsa-miR-20 (sub 1)#
hsa-miR-200a hsa-miR-200a
hsa-miR-23b hsa-miR-23a
hsa-miR-10a hsa-miR-10b

Correlation coeﬃcient
0.99
0.99
0.99
0.99
0.99
0.98
0.98
0.97
0.97
0.97
0.97
0.97
0.97
0.96
0.96
0.96
0.96
0.96
0.96
0.96
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Figure 5: miRNA data analysis: Tests of logistic regression coeﬃcients. Plot
of sorted adjusted p-values for bootstrap-based single-step maxT Procedure
3.
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Figure 6: miRNA data analysis: Tests of correlation coeﬃcients. Plot of
sorted adjusted p-values for bootstrap-based single-step maxT Procedure 3.
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miRNA

miRNA

Figure 7: miRNA data analysis: HOPACH clustering of miRNA expression
proﬁles using correlation distance. The ﬁgure provides a pseudo-color image
of the 155 × 155 correlation matrix for the expression proﬁles of the J = 155
miRNAs, with rows and columns ordered according to the ﬁnal level of the
hierarchical tree of miRNA clusters. Pairwise correlations not signiﬁcantly
diﬀerent from zero are displayed in black. Remaining correlations are represented using a white (anti-correlated) to red (positively-correlated) color
palette. Groups of co-expressed miRNAs appear as red blocks on the diagonal of the correlation matrix. The twenty most signiﬁcantly correlated pairs
of miRNAs from Table 3 are marked in blue.
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